Specifically, FSP1 promotes mitochondrial biogenesis by activating the sirtuin 1 (SIRT1)/peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α) axis, thereby enhancing the metabolic activity and invasive capacity of tumor cells [48]. The gene discussed is AIFM2; the disease is neoplasm.